APA (7th ed.) Citation

Ngo, K. J., Wong, D. Y., Huang, A. Y., Lee, H., Nelson, S. F., & Fogel, B. L. (2025). Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2. Molecular medicine (Cambridge, Mass.), 31(1), 205-14. https://doi.org/10.1186/s10020-025-01257-8

Chicago Style (17th ed.) Citation

Ngo, Kathie J., Darice Y. Wong, Alden Y. Huang, Hane Lee, Stanley F. Nelson, and Brent L. Fogel. "Developing a Disease-specific Accessible Transcriptional Signature as a Biomarker for Ataxia with Oculomotor Apraxia Type 2." Molecular Medicine (Cambridge, Mass.) 31, no. 1 (2025): 205-14. https://doi.org/10.1186/s10020-025-01257-8.

MLA (9th ed.) Citation

Ngo, Kathie J., et al. "Developing a Disease-specific Accessible Transcriptional Signature as a Biomarker for Ataxia with Oculomotor Apraxia Type 2." Molecular Medicine (Cambridge, Mass.), vol. 31, no. 1, 2025, pp. 205-14, https://doi.org/10.1186/s10020-025-01257-8.